US$ 26.87
eli lilly glp-1 receptor agonist medications Shortages improve for Lilly's weight loss drugs, bumping sales forecast by $3bn Eli Lilly's Obesity Pill Appears
Description
Overall it is a promising early-stage result for a convenient oral option, but it's still a couple of trial phases away from being an approved medication

Article written by Ginny Fisher, RN, BSN, CCM, Managed Care Specialist for Summit Reinsurance Services, Inc

Liu, Y., Hu, Z., Wang, J., Liao, Y
Severe kidney disease The gastrointestinal side effects of weight-loss injections (nausea, vomiting, diarrhoea) can cause dehydration, which can worsen existing kidney function
2020 [citato 1 gennaio 7d.C.];14(4):28992
These medications mimic a natural hormone to regulate appetite and promote fat loss